74 related articles for article (PubMed ID: 2856771)
1. Inhibition of the renin-angiotensin-aldosterone axis by low dose intravenous captopril as a treatment for accelerated phase hypertension.
Padfield PL; Rademaker M; Atherden SM; Davies E; Edwards CR; Eglen A; Williams BC
J Hypertens Suppl; 1985 Dec; 3(3):S475-7. PubMed ID: 2856771
[TBL] [Abstract][Full Text] [Related]
2. [Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension].
Posadas C; Sánchez G; Boyer JL; Delmar M; Serrano PA
Arch Inst Cardiol Mex; 1982; 52(4):295-300. PubMed ID: 6291470
[TBL] [Abstract][Full Text] [Related]
3. Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems.
Ohman KP; Karlberg BE; Nilsson OR; Wettre S
Acta Med Scand Suppl; 1981; 646():98-105. PubMed ID: 7018190
[TBL] [Abstract][Full Text] [Related]
4. A discrepancy between the effects of a single oral dose of captopril on blood pressure, plasma renin activity, and serum angiotensin-converting enzyme levels.
Lechi A; Covi G; Capuzzo MG; Lechi C; Minuz P; Delva P; Scuro LA
Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):569-74. PubMed ID: 6317579
[TBL] [Abstract][Full Text] [Related]
5. Relationship between vasopressin and the renin-angiotensin-aldosterone system in essential hypertension: effect of converting enzyme inhibitor on plasma vasopressin.
Santucci A; Leonetti Luparini R; Ferri C; Ficara C; Giarrizzo C; Balsano F
J Hypertens Suppl; 1985 Nov; 3(2):S133-4. PubMed ID: 3003302
[TBL] [Abstract][Full Text] [Related]
6. Blood pressure effects of acute intravenous renin or oral angiotensin converting enzyme inhibition in essential hypertension.
Azizi M; Guyene TT; Chatellier G; Ménard J
J Hypertens; 1994 Apr; 12(4):419-27. PubMed ID: 8064166
[TBL] [Abstract][Full Text] [Related]
7. [Captopril in the treatment of essential hypertension (author's transl)].
Lederle RM; Klaus D; Braun B
Dtsch Med Wochenschr; 1980 Sep; 105(38):1307-12. PubMed ID: 6257467
[TBL] [Abstract][Full Text] [Related]
8. Effects of captopril on blood pressure and renin-angiotensin-aldosterone system in hypertensive subjects after inhibition of renal vasodilative system.
Santucci A; Aguglia F; De Mattia G; Cammarella I; Giordano M; Gnecchi M; Trinchieri F; Ficara C
Int J Clin Pharmacol Res; 1984; 4(1):41-5. PubMed ID: 6381343
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness and safety of captopril (Tensiomin) in patients with hypertension.
Török E; Bíró V; Wagner M; Kósa E; Podmaniczky M; Cseh K
Acta Physiol Hung; 1988; 72 Suppl():51-65. PubMed ID: 2908092
[TBL] [Abstract][Full Text] [Related]
10. Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping.
Bing RF; Russell GI; Swales JD; Thurston H
J Lab Clin Med; 1981 Aug; 98(2):302-10. PubMed ID: 7019368
[TBL] [Abstract][Full Text] [Related]
11. Effects of enalapril maleate on blood pressure, renin-angiotensin-aldosterone system, and peripheral sympathetic activity in essential hypertension.
Cerasola G; Cottone S; D'Ignoto G; Grasso L; Carone MB; Carapelle E; Contorno A
Clin Ther; 1987; 9(4):390-9. PubMed ID: 3038326
[TBL] [Abstract][Full Text] [Related]
12. Plasma vasopressin as influenced by acute and chronic blockade of the renin-angiotensin system.
Stanek B; Bruckner U; Silberbauer K
J Hypertens Suppl; 1985 Nov; 3(2):S129-31. PubMed ID: 3003301
[TBL] [Abstract][Full Text] [Related]
13. Effect of exogenous angiotensin II infusion after one year of captopril therapy in essential hypertension.
Ruilope LM; Miranda B; Robles RG; Hammond TG; Sancho J; Romero JC; Rodicio JL
Postgrad Med J; 1986; 62 Suppl 1():90-3. PubMed ID: 3534868
[TBL] [Abstract][Full Text] [Related]
14. Treatment of malignant hypertension with an angiotensin converting enzyme inhibitor.
Cottone S; Mangano MT; Fulantelli MA; Cerasola G; Salerno L; Nardi E; Lodato G; Traina C
Clin Ther; 1989; 11(4):511-20. PubMed ID: 2550135
[TBL] [Abstract][Full Text] [Related]
15. The state and responsiveness of the renin-angiotensin-aldosterone system in patients with type II diabetes mellitus.
Price DA; De'Oliveira JM; Fisher ND; Williams GH; Hollenberg NK
Am J Hypertens; 1999 Apr; 12(4 Pt 1):348-55. PubMed ID: 10232494
[TBL] [Abstract][Full Text] [Related]
16. Antihypertensive activity of captopril (SQ 14,225), an orally active inhibitor of angiotensin converting enzyme in conscious two-kidney perinephritic hypertensive dogs.
Vollmer RR; Boccagno JA; Steinbacher TE; Horovitz ZP; Murthy VS
J Pharmacol Exp Ther; 1981 Feb; 216(2):225-31. PubMed ID: 6257882
[TBL] [Abstract][Full Text] [Related]
17. Acute effects of a pseudo-tetrapeptide as renin inhibitor on blood pressure and renin-angiotensin system of sodium-repleted and sodium-depleted hypertensive patients.
Denolle T; Luo P; Guyene TT; Cazaubon C; Sissmann J; Corvol P; Ménard J
Arzneimittelforschung; 1993 Feb; 43(2A):255-9. PubMed ID: 8498973
[TBL] [Abstract][Full Text] [Related]
18. Dissociation of renin and aldosterone during low-dose epinephrine infusion.
Kruse HJ; Kreutz R; Staib S; Overlack A; Stumpe KO; Kolloch RE
Am J Hypertens; 1994 Oct; 7(10 Pt 1):913-8. PubMed ID: 7826555
[TBL] [Abstract][Full Text] [Related]
19. Combined treatment with minoxidil and captopril in refractory hypertension.
Traub YM; Levey BA
Arch Intern Med; 1983 Jun; 143(6):1142-4. PubMed ID: 6344825
[TBL] [Abstract][Full Text] [Related]
20. Effects of prolonged and brief infusions of noradrenaline on arterial pressure and on the plasma concentrations of active renin, angiotensin II, aldosterone and potassium.
Casals-Stenzel J; Tree M; Brown JJ; Fraser R; Lever AF; Millar JA; Morton JJ; Robertson JI; Reid JL; Hamilton C
J Hypertens; 1983 Jun; 1(1):27-35. PubMed ID: 6397510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
